Merit Medical Systems (MMSI) Cash & Equivalents (2010 - 2026)

Merit Medical Systems has reported Cash & Equivalents for 17 years, with the latest figure at $448.7 million in Q2 2026.

• Quarterly Cash & Equivalents rose 31.27% year-over-year to $448.7 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $448.7 million (up 31.27% YoY) and the FY2025 annual result came in at $446.4 million, up 18.5% from the prior year.
• Cash & Equivalents eased to $448.7 million in Q2 2026 per MMSI's latest filing, from $488.1 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $636.7 million in Q2 2024 and troughed at $51.5 million in Q3 2022.
• A 5-year average of $313.0 million and a median of $384.6 million in 2024 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2023 and 2025: Cash & Equivalents jumped 905.06% in 2023, then slumped 46.31% in 2025.
• Over 5 years, Cash & Equivalents stood at $58.4 million in 2022, then surged by 905.06% to $587.0 million in 2023, then sank by 35.83% to $376.7 million in 2024, then rose by 18.5% to $446.4 million in 2025, then rose by 0.51% to $448.7 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $448.7 million, $488.1 million, and $446.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.